• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2023 Fiscal Year Final Research Report

Mechanism of gastric cancer naturally development in novel glycan deficient mice

Research Project

  • PDF
Project/Area Number 20K09053
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Review Section Basic Section 55020:Digestive surgery-related
Research InstitutionShinshu University

Principal Investigator

Harumiya Satoru  信州大学, 医学部, 特任准教授 (50301792)

Co-Investigator(Kenkyū-buntansha) 中山 淳  信州大学, 学術研究院医学系, 教授 (10221459)
Project Period (FY) 2020-04-01 – 2024-03-31
Keywords胃癌 / 糖鎖 / 糖転移酵素 / 遺伝子改変マウス
Outline of Final Research Achievements

To elucidate the mechanism of gastric carcinogenesis in A4gnt knockout (KO) mice, the regulation of IL-11 signaling activation was investigated. Activation of the JAK2―STAT3 pathway and increased gp130 expression were observed in the gastric mucosa of A4gnt KO mice. Analysis of wild-type mouse gastric mucosa and AGS cells suggested that αGlcNAc binds to IL-11 receptors and gp130, thus preventing the formation of the IL-11/IL-11 receptor/gp130 complex and suppressing STAT3 activation. These results suggest that the gastric tumorigenesis naturally development in A4gnt KO mice can be caused by enhanced activity of IL-11―JAK2―STAT3 signaling pathway.

Free Research Field

生化学 糖鎖生物学

Academic Significance and Societal Importance of the Research Achievements

αGlcNAcの欠損による胃分化型癌の発生機構として、発癌シグナルであるIL-11―JAK2―STAT3経路が活性化されることを明らかにした。たった1つの糖の欠損という僅かな変化が原因で胃に生じる顕著な表現型が癌関連シグナルの活性化によるという事実は、糖鎖病理学領域における新知見であり、学術的意義がある。また、これらの結果からαGlcNAcによる癌関連シグナルの抑制は、新たな胃癌の予防、治療法開発への研究基盤になることが期待できる。

URL: 

Published: 2025-01-30  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi